The Latest Breaking News on Analysis

Parents aren’t heeding the warnings, despite 49% being concerned about their children’s mental health, according to a new report.

Depending on what you think of Donald Trump, his administration could fit either of the following two descriptions. Chaotic, vindictive and accident-prone, marked by mendacity, driven by impulse and bent on securing the will of the leader, rather than – as in the US constitution – the will of the…

To protect businesses, the economy, and critical infrastructure, cybersecurity must radically rethink its approach.

The president gleefully predicted that the cost to consumers could be as much as 10 times higher.

Over 40 DEA agents packed the Brooklyn federal courtroom this week, their presence a silent tribute to their fallen comrade, Enrique "Kiki" Camarena, during the drug dealer's second audience.

FBI Director Kash Patel may not have been part of a Signal chat in which other Trump administration national security officials discussed detailed attack plans

Débora Albuquerque scrawled “You lost, dude” on a statue. Now she’s being treated like a national security threat.

A maritime ceasefire deal to allow the safe passage of ships and end the use of force in the Black Sea could soon come into effect. Brokered over the past two weeks by the United States and agreed to by both Russia and Ukraine, it has immediately raised concerns that…

As the 19th-century French political philosopher, Alexis de Tocqueville, memorably observed, Americans have a tendency to fight their political battles in court. Barely two months into his presidency, Donald Trump is demonstrating increasing frustration as trade unions, civil rights organisations and states attorneys general challenge the implementation of his policies…

The Trump administration’s firing and furloughing of tens of thousands of federal workers and contractors have obviously caused economic hardship for Americans employed in national parks, research labs and dozens of government agencies.

Critics worry that the user fee program creates a conflict of interest between the FDA and pharmaceutical companies.